ANTI-21-HYDROXYLASE ANTIBODY - ANVISA Registration 80464810575

Access comprehensive regulatory information for ANTI-21-HYDROXYLASE ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810575 and manufactured by MEDIPAN GMBH. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
80464810575
Registration Details
ANVISA Registration Number: 80464810575
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

MediZym ® anti-21-OH
Risk Class II

Registration Details

80464810575

25351722111201778

09377976000152

Company Information

MEDIPAN GMBH
Germany
PT: ALEMANHA

Dates and Status

Jun 04, 2018

VIGENTE

09/18/2025 19:00:01